Tag Archives: coronary disease

SOLACI-CACI 2021 Virtual

SOLACI-CACI 2021 | Current & Immediate Future Role of Imaging in Structural and Coronary Heart Disease

SOLACI-CACI 2021 | Current & Immediate Future Role of Imaging in Structural and Coronary Heart Disease

✔️ Watch again the session “Current & Immediate Future Role of Imaging in Structural and Coronary Heart Disease” in the SOLACI-CACI 2021 Congress. 👨‍🏫 Program: 02:27 – Computer Tomography in TAVR: Planning, Predicting Complications, and Follow-up – Mariano Falconi 19:26 – Multi-Imaging Evaluation in Mitral Regurgitation Intervention – Fabián Salmo 31:10 – New Prognosis Tools

SOLACI-CACI 2021 Virtual

SOLACI-CACI 2021 | Cardiovascular Disease Management and Cath Lab During the COVID-19 Pandemic

✔️ Watch again the session on Cardiovascular Disease Management and Cath Lab During the COVID-19 Pandemic in the SOLACI-CACI 2021 Congress. 👨‍🏫 Program: 04:55 – Thromboembolic Complications in COVID – José Ceresetto 27:59 – Global Registry of Acute Myocardial Infarction of Primary PCI in COVID Era – Giuseppe De Luca 53:36 – Infectious Disease Care in

Monto de isquemia basal en pacientes con múltiples vasos y evolución a largo plazo

A Headache for Cardiologists: Ischemia with Non-Obstructive Disease

Treating patients with functional stress test induced ischemia and non-obstructive coronary artery disease (INOCA) is complex and often frustrating.  The multifactorial nature of this disease in addition to the complex physiopathological relationship between angina and ischemia turn these patients into a real headache for cardiologists. The CIAO-ISCHEMIA was recently published in Circulation and was designed

ffr tomografia

CT and Angiography Agreement in Patients from the ISCHEMIA Trial

Computed tomographic (CT) angiography showed a high degree of agreement with conventional angiography to detect significant coronary artery disease and rule out left main disease. This imaging study was done on a group of patients before their randomization in the ISCHEMIA trial. Data are soon to be published in JACC Cardiovascular Imaging and add plenty

El éxito en las CTO reduce la isquemia residual local y a distancia

Revascularization Is Needed Before TAVR

Disease prevalence in patients with severe aortic stenosis is highly variable: from 80% in inoperable patients to only 15% according to the most recent research including low-risk patients. Given the high mortality observed in patients with heart disease, guidelines suggest considering coronary bypass revascularization in those in need of a valve replacement. This experience with


ISCHEMIA: New Analysis Might Change Study Outcome Interpretation

A new ISCHEMIA analysis has shown its outcomes are highly dependent on MI definition. The original conclusion had shown a significant difference between invasive and conservative strategies using the most sensible definition of MI: troponin elevation.  When looking at events using MI definition as troponin elevation, we will see the conservative treatment reduces primary end

Efecto a largo plazo de los balones liberadores con bajas dosis de paclitaxel

Global FFR as Prognosis in CAD Patients without Ischemia

Global fractional flow reserve (FFR) results from adding up FFR values of the three major coronary arteries. This figure represents the physiological atherosclerosis burden and can predict events at long term in patients without stenosis leading to ischemia. This recent study published in JAHA looked at major cardiovascular events (death, infarction and revascularization) at 5

AHA 2020 | AFFIRM-AHF: Suplemento de hierro y menos hospitalizaciones por insuficiencia cardíaca

AHA 2020 | Effect of Evolocumab in Complex Coronary Revascularization

Evolocumab, a PCSK9 inhibitor, has shown significant reduction of complex coronary disease requiring revascularization (be it PCI or CABG). Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors induce plaque regression and could eventually reduce the risk of coronary revascularization, especially complex revascularization.  The FOURIER study randomized 27564 patients with stable CAD already on statins to evolocumab

Stress mental, activación de la corteza frontal y angina de pecho

Mental Stress, Frontal Lobe Activation and Chest Pain

Historically, we have believed that mental stress might induce chest pain as a response to increased levels of catecholamines and consequently increased product (by 100%), just as it happens with physical stress.  This innovative study published in Circ Cardiovasc Imaging shows the activation of specific areas in the brain is independently associated with chest pain